Havrix 720 Junior Description

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

One dose (0.5 mL) of Havrix 720 Junior contains: Hepatitis A virus (inactivated)^1,2720 ELISA Units.
¹Produced on human diploid (MRC-5) cells.
²Adsorbed on aluminium hydroxide, hydrated 0.25 milligrams Al³⁺.
Upon storage, a fine white deposit with a clear colourless supernatant can be observed.
Excipients/Inactive Ingredients: Amino acids for injections, disodium phosphate, monopotassium phosphate, polysorbate 20, potassium chloride, sodium chloride, water for injections.
Neomycin sulphate is present as residual from the manufacturing process.

Havrix 720 Junior Description

vaccine, hepatitis a

Manufacturer:

GlaxoSmithKline Indonesia